Pml represses tumour progression through inhibition of mTOR.
Pml represses tumour progression through inhibition of mTOR.
复制标题
DOI:
10.1002/emmm.201100130
复制
发表时间:
2011-05
影响因子:
11.1
通讯作者:
Pandolfi, Pier Paolo
中科院分区:
文献类型:
--
作者:
Bernardi, Rosa;Papa, Antonella;Egia, Ainara;Coltella, Nadia;Teruya-Feldstein, Julie;Signoretti, Sabina;Pandolfi, Pier Paolo
The promyelocytic leukaemia gene PML is a pleiotropic tumour suppressor. We have recently demonstrated that PML opposes mTOR-HIF1α-VEGF signalling in hypoxia. To determine the relevance of PML-mTOR antagonism in tumourigenesis, we have intercrossed Pml null mice with Tsc2 heterozygous mice, which develop kidney cysts and carcinomas exhibiting mTOR upregulation. We find that combined inactivation of Pml and Tsc2 results in aberrant TORC1 activity both in pre-tumoural kidneys as well as in kidney lesions. Such increase correlates with a marked acceleration in tumour progression, impacting on both the biology and histology of kidney carcinomas. Also, Pml inactivation decreases the rate of loss of heterozygosity (LOH) for the wt Tsc2 allele. Interestingly, however, aberrant TORC1 activity does not accelerate renal cystogenesis in Tsc2/Pml mutants. Our data demonstrate that activation of mTOR is critical for tumour progression, but not for tumour initiation in the kidney.
登录
查看更多内容
影响因子:
3.5
作者:
Zhou, Jing;Brugarolas, James;Parada, Luis F.
通讯作者:
Parada, Luis F.
影响因子:
10.5
作者:
Ma, L;Teruya-Feldstein, J;Pandolfi, PP
通讯作者:
Pandolfi, PP
影响因子:
3.5
作者:
Bonnet, Cleo S.;Aldred, Mark;Cheadle, Jeremy P.
通讯作者:
Cheadle, Jeremy P.
影响因子:
64.8
作者:
Bernardi, Rosa;Guernah, Ilhem;Pandolfi, Pier Paolo
通讯作者:
Pandolfi, Pier Paolo
影响因子:
3.9
作者:
Huang J;Manning BD
通讯作者:
Manning BD